Protective effects of imipramine in murine endotoxin-induced acute lung injury.

Jin Yang,Jie-ming Qu,Hanssa Summah,Jin Zhang,Ying-gang Zhu,Hong-ni Jiang
DOI: https://doi.org/10.1016/j.ejphar.2010.04.005
IF: 5.195
2010-01-01
European Journal of Pharmacology
Abstract:The tricyclic antidepressant imipramine has recently emerged as a cytoprotective agent, exerting beneficial effects in inflammatory tissue injury. The present study aimed to investigate therapeutic effects of imipramine in murine model of endotoxin-induced acute lung injury. Mice were administrated intraperitoneally with LPS (lipopolysaccharide) from Escherichia coli or vehicle. Imipramine was administrated intraperitoneally 30min before LPS challenge. Pretreatment of mice with imipramine reduced lethality. Impramine also significantly attenuated lung inflammation, lung edema, MPO (myeloperoxidase) activity, lung tissue pathological changes and nuclear factor-κB DNA binding activity. The results of this study suggest that imipramine can exert protective effects in endotoxin-induced acute lung injury by suppressing nuclear factor-κB-mediated expression of inflammatory genes. Thus, imipramine could be a potential novel therapeutic agent for the treatment for acute lung injury.
What problem does this paper attempt to address?